Nightdive Studios, the developer behind remasters of Star Wars: Dark Forces and System Shock 2 , have surprise-launched a remaster of 2002 cult-hit The Thing . The upgraded game is available now for PC, Xbox One and Series X/S, PlayStation 4 and 5, Nintendo Switch, and to stream through NVIDIA GeForce Now. Originally developed by Computer Artworks, The Thing is a third-person shooter that acts a direct sequel to John Carpenter’s 1984 film The Thing , following a United States Special Forces team that’s sent into the film’s arctic base to investigate what happened there. Outside the source material, the game is best known for its trust, fear, and infection systems. How you play can impact whether in-game characters trust you, think you’re The Thing or turn into The Thing themselves. With The Thing Remastered , Nightdive is carrying over the original’s core mechanics and updating the visuals and engine to run on modern consoles. Now you can play in 4K at up to 120 fps, with improved “character models, textures, and animations,” according to Nightdive’s announcement, and “advanced 3D rendering for updated lighting and atmospheric effects.” The game also includes trophies and achievements on PC, PlayStation and Xbox, if you’re looking for that, too. A remastered version of The Thing was originally announced in June 2024 at IGN Live, the latest in a series of remastered game projects Nightdive Studios has announced in the last few years. The studio was formed in 2012 to make System Shock 2 playable on modern PCs, but has worked on everything from the Turok games to Blade Runner: Enhanced Edition , since then. The Thing Remastered is available digitally for $29.99 on Steam (where it’s Steam Deck Verified), GOG, the Microsoft Store, the PlayStation Store and the Nintendo eShop.Anderson, Lapel kick off holiday season

Some broker love for RAS Tech and ChrysosNone

When Supreme Court justices debated Tennessee’s ban on gender-affirming care yesterday, they kept calling the science “evolving” and “uncertain. ” Last year, Tennessee made it illegal for doctors to provide gender-affirming care to trans teens. Their reason? The state claims it needs to make sure young people don’t become “disdainful of their sex” — that’s the actual language in the law. That’s not how medicine works, doctors say. “When we ban care or slow down care, we’re affecting an entire age cohort and putting them at risk for worse mental health,” says Dr. Carl Streed Jr., who leads the World Professional Association for Transgender Health’s U.S. chapter and runs research at Boston Medical Center’s GenderCare Center, told USA Today . The state’s case leans heavily on claims about medical uncertainty. But Dr. Joshua Safer, who heads Mount Sinai’s transgender medicine center in New York, also told USA Today the approach for treating trans youth is already “conservative” and carefully individualized. “We try to be thoughtful and conservative when we support parents and kids,” he said. What Tennessee’s law actually does is block doctors from using the same medications for trans kids that they can freely prescribe to other youth for different conditions. It’s this bizarre contradiction that’s now before the Supreme Court. Major medical organizations filed receipts with the Court in the form of amicus briefs. The American Academy of Pediatrics brought the data : Studies show that access to puberty blockers and hormone therapy, when prescribed according to established guidelines, significantly reduces mental health crises for trans youth who need them. But Tennessee’s case relies heavily on six doctors—and that’s where things get sketchy. A recent investigation by Accountable.US found that courts have repeatedly called out four of these experts for: Lack of relevant experience treating trans patients Relying on questionable methodology Making claims unsupported by peer-reviewed research These are the basic facts that got buried in court: Puberty blockers are reversible. Full stop. The Mayo Clinic confirms that when you stop taking them, puberty resumes. Gender-affirming surgeries for minors are extremely rare . The feds pointed this out, noting the Tennessee case isn’t even about surgery access. Mental health impacts are documented: The September 2024 Nature Human Behavior study found that anti-trans laws correlate with increased suicide attempts among trans teens. While Justice Roberts called this an “evolving situation,” medical groups say the basic science is solid. What’s actually evolving is the political fight—25 states have passed similar bans despite major medical associations opposing them. RECOMMENDED • pennlive .com 2024-25 Mid-Penn Commonwealth boys swimming preview: predictions and preseason MVPs Dec. 3, 2024, 5:00 a.m. Chart-topping ‘90s band cancels upcoming shows after singer ends up in hospital: ’We’re heartbroken' Dec. 4, 2024, 7:37 a.m. The American Medical Association’s position is clear: “Trans and non-binary gender identities are normal variations of human identity and expression.” They warn that blocking care access can have “tragic health consequences.” The Court will rule by June. At stake isn’t just Tennessee’s law— similar bans in 25 other states could be affected. For trans teens and their doctors caught in the middle, the wait continues.

Robbins LLP reminds investors of the class action filed on behalf of all persons and entities that purchased or otherwise acquired Humacyte, Inc. (NASDAQ: HUMA) securities between May 10, 2024 and October 17, 2024. Humacyte and its consolidated subsidiaries develop and manufacture off-the-shelf, implantable, and bioengineered human tissues. For more information, submit a form , email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. The Allegations: Robbins LLP is Investigating Allegations that Humacyte, Inc (HUMA) Misled Investors Regarding its Manufacturing Practices According to the complaint, Humacyte is currently engaged in engineering and manufacturing Acellular Tissue Engineered Vessel (“ATEV”), also known as“Human Acellular Vessel,” which is a lab-grown blood vessel implant that can act as a replacement for an injured or damaged blood vessel. On August 9, 2024, Humacyte issued a press release announcing that the FDA“will require additional time to complete its review of its Biologic License Application (BLA) for the acellular tissue engineered vessel (ATEV) in the vascular trauma indication.” The press release disclosed in part, that,“[d]uring the course of the BLA review, the FDA has conducted inspections of our manufacturing facilities and clinical sites and has actively engaged with us in multiple discussions regarding our BLA filing[.]” On this news, the Company's stock price declined $1.29, or 16.4%, to close at $6.62 per share on August 12, 2024. The complaint further alleges that on October 17, 2024, the FDA released a Form 483 concerning Humacyte's Durham, North Carolina facility, which revealed violations, including“no microbial quality assurance,”“no microbial testing,” and inadequate“quality oversight.” On this news, the Company's stock price declined $0.95, or 16.35%, to close at $4.86 per share on October 17, 2024. Plaintiff alleges that during the class period, defendants failed to disclose to investors: (1) that the Company's Durham, North Carolina facility failed to comply with good manufacturing practices, including quality assurance and microbial testing; (2) that the FDA's review of the BLA would be delayed while Humacyte remediated these deficiencies; and (3) that, as a result, there was a substantial risk to FDA approval of ATEV for vascular trauma. What Now : You may be eligible to participate in the class action against Humacyte, Inc. Shareholders who want to serve as lead plaintiff for the class must submit their application to the court by January 17, 2025. A lead plaintiff is a representative party who acts on behalf of other class members in directing the litigation. You do not have to participate in the case to be eligible for a recovery. If you choose to take no action, you can remain an absent class member. For more information, click here . All representation is on a contingency fee basis. Shareholders pay no fees or expenses. About Robbins LLP : Some law firms issuing releases about this matter do not actually litigate securities class actions; Robbins LLP does. A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LL have been dedicated to helping shareholders recover losses, improve corporate governance structures, and hold company executives accountable for their wrongdoing since 2002. Since our inception, we have obtained over $1 billion for shareholders. To be notified if a class action against Humacyte, Inc. settles or to receive free alerts when corporate executives engage in wrongdoing, sign up for Stock Watch today. Attorney Advertising. Past results do not guarantee a similar outcome. A photo accompanying this announcement is available at MENAFN24122024004107003653ID1109028402 Legal Disclaimer: MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.

Microsoft is taking away the Xbox Avatar EditorBriefly | $77 million in federal dollars going to Colorado Springs semiconductor manufacturerThe rivalry between No. 6 Notre Dame and No. 17 Army is back and it has major playoff implications. The Fighting Irish (9-1) and the Black Knights (9-0) will face off against each other at Yankee Stadium on Saturday , marking the first matchup between the two programs since 2016, when Notre Dame handily defeated Army, 44-6. Notre Dame has beaten Army in the last 15 matchups and hasn't dropped a game in the series since 1958. Both Notre Dame and Army are vying for a spot in the expanded 12-team College Football Playoff . Notre Dame got off to a rough start this season after suffering a shocking upset to Northern Illinois in Week 2 , but the Fighting Irish were projected to be the No. 8 seed in the latest College Football Playoff bracket after winning their last eight games. Army, on the other hand, is undefeated and has already secured a spot in the American Athletic Conference championship game against Tulane in December, but a win over ranked Notre Dame will only bolster their resume. Can Army snap Notre Dame's 15-game winning streak? Can the Fighting Irish keep their playoff hopes alive? Here's how to tune into the matchup on Saturday: WEEK 13 GAMES TO WATCH: Ohio State, Notre Dame face tests on Saturday ARMY: Readies for Notre Dame with playoff possibilites on the line When is Army vs. Notre Dame? Kickoff is set for Saturday, Nov. 23 at 7 p.m. ET from Yankee Stadium in New York. How to watch Army vs. Notre Dame? Saturday's matchup between No. 6 Notre Dame and No. 17 Army will be broadcast nationally on NBC. The game can also be streamed on Peacock and Fubo . The USA TODAY app gets you to the heart of the news — fast . Download for award-winning coverage, crosswords, audio storytelling, the eNewspaper and more . We occasionally recommend interesting products and services. If you make a purchase by clicking one of the links, we may earn an affiliate fee. USA TODAY Network newsrooms operate independently, and this doesn’t influence our coverage.

Drag Queen story-time target of another threat

Enfusion stock hits 52-week high at $10.4 amid growth optimismDataBank Ranks Among Fastest-Growing Companies in North America on the 2024 Deloitte Technology Fast 500TMJudge dismisses charges against Karen Read supporter who scattered rubber ducks and fake $100 bills

Mike Redding is used to coaching against teams for a second time come the tournament. This time, the repeat meeting will take place at Gillette Stadium. Just five weeks after coming up short against them in week eight to finish the regular season, No. 3 Mansfield will look to take down Hockomock Davenport foe North Attleboro in the Division 3 Super Bowl on Friday at 8 p.m. The Red Rocketeers handed Mansfield its only league loss of the fall, defeating the Hornets 14-10 on Oct. 25. From 2017-19, Mansfield faced then Kelley-Rex rival King Philip in the regular season only to then face them in the postseason. The Hornets fared better in each of those matchups the second time around. Redding is hoping that pattern holds. “You definitely learn some stuff the first time around. Teams evolve a bit also over the course of the postseason,” Redding said. “I remember experiencing it with King Philip well and faring better on the scoreboard the second time in each occurrence. I think we’re able to adjust.” The Hornets are led by their ground game of Sean McCoy and Mason Bordieri. McCoy has 15 touchdowns. Quarterback Tommy Vallett has improved as the season has gone on with the junior completing over 75 percent of his passes the second half of the season. Anthony DeGirolamo led the Hockomock in receiving touchdowns with nine. Up front, Sam Dunn, Chris Holts, Arthur DeAguiar, Curtis Riley and Nate Pailler look to dictate the line of scrimmage. Defensively, Riley Sigman, Bordieri and McCoy hold down the secondary. Matt Touringey is a stout outside linebacker. “Coming into the year, I thought we would compete to get into the state tournament and maybe win a playoff game, but I was not necessarily expecting this,” Redding said. “We have really clicked the second half of the season.” North Attleboro is impressing with its postseason run. After defeating Woburn and Westboro by a combined 77-14, the Red Rocketeers defeated top overall seed Reading in the semifinals without star running back and linebacker Ryan Bannon. In Bannon’s place, quarterback Chase Frisoli stepped up against Reading, taking off for 311 yards over 27 carries to go with four scores. Frisoli has 22 touchdowns, with 13 through the air and nine on the ground. When Bannon is on the field he is explosive with 12 total touchdowns. Frankie Strachan is the team’s lead blocker at 6-foot-1, 255 pounds and will get some carries at fullback. Around Frisoli there is no shortage of weapons. Bryce Kiser is the team’s top receiver while Brady Paradis tortures teams on the ground and in the passing game. Corey Rafino adds another dimension at running back. Defensively, Bannon is at the center of it all from his linebacker position. The defensive line is made up of Reid Clemente, Nate Rivera, Patrick Hamilton and Austin Clemente. “Our seniors do a really good job of holding themselves accountable,” head coach Michael Strachan said. “They know how important it is to have a great week of practice. They go back to the basics and do the little things every time.” Mansfield vs. North Attleboro Friday, 8 p.m. at Gillette Stadium Head coach: Mike Redding Mansfield 48, Everett 14 Duxbury 21, Mansfield 0 Mansfield 48, Johnston (RI) 0 Marshfield 13, Mansfield 10 Mansfield 42, Stoughton 0 Mansfield 35, Oliver Ames 7 North Attleboro 14, Mansfield 10 Mansfield 43, Canton 32 Mansfield 42, Doherty 17 Mansfield 14, Dartmouth 6 Mansfield 42, Walpole 28 Mansfield 21, Foxboro 7 Head coach: Mike Strachan North Attleboro 48, Lynn Classical 14 North Attleboro 21, Lynn Classical 6 North Attleboro 42, Taunton 8 North Attleboro 51, Oliver Ames 0 Canton 12, North Attleboro 10 North Attleboro 51, Stoughton 6 North Attleboro 14, Mansfield 10 Foxboro 19, North Attleboro 14 North Attleboro 35, Woburn 7 North Attleboro 42, Westborough 7 North Attleboro 42, Reading 20 North Attleboro 38, Attleboro 8 Mansfield is making its 12th appearance in a championship game and has posted an impressive 8-3 record. The Hornets last played in the final in 2019 when Vinny Holmes rushed for 149 yards and three touchdowns in a 35-0 win over Lincoln-Sudbury to claim the Div. 2 crown. North Attleboro is no stranger to the postseason, having appeared in 11 title games. The last time the Red Rocketeers won a Super Bowl game, it was one for the ages as they defeated Swampscott 44-40 to win the Div. 3 title in 2002. The game is a rematch of an Oct. 25 regular season contest in which North Attleboro emerged victorious in a defensive struggle, 14-10. While I think North Attleboro might be the better team, there is something about Mansfield and its late season run which seems to make me hedge my pick a bit. Pick: MansfieldTORONTO, Dec. 05, 2024 (GLOBE NEWSWIRE) -- White Gold Corp. (TSX.V: WGO, OTCQX: WHGOF, FRA: 29W) (the “Company”) is pleased to announce a non-brokered private placement for gross proceeds of $4,500,000 consisting of the sale of a combination of : (i) common shares in the capital of the Company (“Common Shares”) that qualify as “flow-through shares” within the meaning of the Income Tax Act (Canada) (the “Tax Act”) at a price of C$0.26 per share (each an “FT Share”); (ii) FT Shares that will also qualify for the federal 30% Critical Mineral Exploration Tax Credit at a price of $0.27 per share (each a “CFT Share”); and (iii) Common Shares a price of C$0.22 per share (each an “HD Share”) (the “Offering”). “We are very appreciative for the continued support for our exciting and impactful exploration activities to advance our significant gold deposit which is now one of the highest-grade open pit gold resources in Canada of such significant size owned by an exploration company, and other recent high-grade gold discoveries and additional prospective critical mineral projects on our district scale land package in the prolific and under explored White Gold District,” stated David D’Onofrio, Chief Executive Officer. The gross proceeds received from the sale of the FT Shares will be used to incur (or deemed to incur) “Canadian exploration expenses” as defined in subsection 66.1(6) of the Tax Act, and the gross proceeds from the sale of the CFT Shares will be used to incur (or deemed to incur) eligible “Canadian exploration expenses” that qualify as “flow-through critical mineral mining expenditures” (as both terms are defined in the Tax Act) (collectively, the “Qualifying Expenditures”), related to the Company’s properties in the White Gold District of the Yukon Territory, on or before December 31, 2025, and to renounce all the Qualifying Expenditures in favour of the subscribers of the FT Shares, and CFT Shares effective December 31, 2024. If the Qualifying Expenditures are reduced by the Canada Revenue Agency, the Company will indemnify each subscriber of an FT Share, and CFT Share for any additional taxes payable by such subscriber as a result of the Company’s failure to renounce the Qualifying Expenditures as agreed. The net proceeds from the sale of the Common Shares will be used for working capital and other general corporate purposes. Closing of the Offering is expected to occur on or about December 20, 2024 and is subject to the satisfaction of certain conditions, including receipt of all applicable regulatory approvals including the approval of the TSX Venture Exchange (the “TSXV”). The securities issued pursuant to the Offering will be subject to a statutory hold period of four months plus one day from the closing date of the Offering in accordance with applicable securities legislation. About White Gold Corp. The Company owns a portfolio of 15,876 quartz claims across 26 properties covering approximately 315,000 hectares (3,150 km2) representing approximately 40% of the Yukon’s emerging White Gold District. The Company’s flagship White Gold project hosts four near-surface gold deposits which collectively contain an estimated 1,203,000 ounces of gold in Indicated Resources and 1,116,600 ounces of gold in Inferred Resources(1). Regional exploration work has also produced several other new discoveries and prospective targets on the Company’s claim packages which border sizable gold discoveries including the Coffee project owned by Newmont Corporation with Measured and Indicated Resources of 2.1 Moz at 1.28 g/t gold and Inferred Resources of 0.2 Moz at 1.04 g/t gold(2), and Western Copper and Gold Corporation’s Casino project which has Measured and Indicated Resources of 7.6 Blb copper and 14.5 Moz gold and Inferred Resources of 3.3 Blb copper and 6.6 Moz gold(3). For more information visit www.whitegoldcorp.ca . (1) See White Gold Corp. press release dated November 19, 2024, available on SEDAR+. (2) See Newmont Corporation Form 10-K: Annual report for the year ending December 31, 2023, in the Measured, Indicated, and Inferred Resources section, dated February 29, 2024, available on EDGAR. Reserves and resources disclosed in this Form 10-K have been prepared in accordance with the Regulation S-K 1300, and do not indicate NI43-101 compliance. (3) See Western Copper and Gold Corporation technical report titled “Casino project, Form 43-101F1 Technical Report Feasibility Study, Yukon Canada”, Effective Date June 13, 2022, Issue Date August 8, 2022, NI 43-101 Compliant Technical Report prepared by Daniel Roth, PE, P.Eng., Mike Hester, F Aus IMM, John M. Marek, P.E., Laurie M. Tahija, MMSA-QP, Carl Schulze, P.Geo., Daniel Friedman, P.Eng., Scott Weston, P.Geo., available on SEDAR+. Cautionary Note Regarding Forward Looking Information This news release contains "forward-looking information" and "forward-looking statements" (collectively, "forward-looking statements") within the meaning of the applicable Canadian securities legislation. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release. Any statement that involves discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions, future events or performance (often but not always using phrases such as "expects", or "does not expect", "is expected", "anticipates" or "does not anticipate", "plans", “proposed”, "budget", "scheduled", "forecasts", "estimates", "believes" or "intends" or variations of such words and phrases or stating that certain actions, events or results "may" or "could", "would", "might" or "will" be taken to occur or be achieved) are not statements of historical fact and may be forward-looking statements. In this news release, forward-looking statements relate, among other things, the Offering, including all regulatory approvals; the use of proceeds from the Offering; the Company’s objectives, goals and exploration activities conducted and proposed to be conducted at the Company’s properties; future growth potential of the Company, including whether any proposed exploration programs at any of the Company’s properties will be successful; exploration results; and future exploration plans and costs and financing availability. These forward-looking statements are based on reasonable assumptions and estimates of management of the Company at the time such statements were made. Actual future results may differ materially as forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company to materially differ from any future results, performance or achievements expressed or implied by such forward-looking statements. Such factors, among other things, include: the expected benefits to the Company relating to the exploration conducted and proposed to be conducted at the White Gold properties; the receipt of all applicable regulatory approvals for the Offering; the completion of the Offering on the terms described herein, or at all; failure to identify any additional mineral resources or significant mineralization; the preliminary nature of metallurgical test results; uncertainties relating to the availability and costs of financing needed in the future, including to fund any exploration programs on the Company’s properties; business integration risks; fluctuations in general macroeconomic conditions; fluctuations in securities markets; fluctuations in spot and forward prices of gold, silver, base metals or certain other commodities; fluctuations in currency markets (such as the Canadian dollar to United States dollar exchange rate); change in national and local government, legislation, taxation, controls, regulations and political or economic developments; risks and hazards associated with the business of mineral exploration, development and mining (including environmental hazards, industrial accidents, unusual or unexpected formations pressures, cave-ins and flooding); inability to obtain adequate insurance to cover risks and hazards; the presence of laws and regulations that may impose restrictions on mining and mineral exploration; employee relations; relationships with and claims by local communities and indigenous populations; availability of increasing costs associated with mining inputs and labour; the speculative nature of mineral exploration and development (including the risks of obtaining necessary licenses, permits and approvals from government authorities); the unlikelihood that properties that are explored are ultimately developed into producing mines; geological factors; actual results of current and future exploration; changes in project parameters as plans continue to be evaluated; soil sampling results being preliminary in nature and are not conclusive evidence of the likelihood of a mineral deposit; title to properties; and those factors described in the most recently filed management’s discussion and analysis of the Company. Although the forward-looking statements contained in this news release are based upon what management of the Company believes, or believed at the time, to be reasonable assumptions, the Company cannot assure shareholders that actual results will be consistent with such forward-looking statements, as there may be other factors that cause results not to be as anticipated, estimated or intended. Accordingly, readers should not place undue reliance on forward-looking statements and information. There can be no assurance that forward-looking information, or the material factors or assumptions used to develop such forward-looking information, will prove to be accurate. The Company does not undertake to release publicly any revisions for updating any voluntary forward-looking statements, except as required by applicable securities law. Neither the TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this news release. Contact Information: David D’Onofrio Chief Executive Officer White Gold Corp. (647) 930-1880 ir@whitegoldcorp.caBankwell Financial Group's director Blake Drexler purchases $427 of stock

Helping people overcome one of their greatest fears — public speaking